Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05).Completed
NCT00242307Phase 2, Phase 3Updated Jun 10, 2026
Sponsor: AstraZeneca
Bronchial Asthma
Japan
Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07).Completed
NCT00246922Phase 3Updated Jun 10, 2026
Sponsor: AstraZeneca
Bronchial Asthma
Japan
A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based ChemotherapyTerminated
NCT06267001Phase 3Updated Jun 10, 2026
Sponsor: Hoffmann-La Roche
Non-small Cell Lung Cancer (NSCLC)
Argentina, Australia, Brazil, China, Italy +6 more
A Phase 3 Study of ALXN2060 in Japanese Participants With Symptomatic ATTR-CMCompleted
NCT04622046Phase 3Updated Jun 10, 2026
Sponsor: Alexion Pharmaceuticals, Inc.
Symptomatic Transthyretin Amyloid Cardiomyopathy
Japan
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid ArthritisCompleted
NCT03971253N/AUpdated Jun 10, 2026
Sponsor: Astellas Pharma Inc
Rheumatoid Arthritis (RA)
Japan
Study of Epetraborole in Patients With Treatment-refractory MAC Lung DiseaseTerminated
NCT05327803Phase 2, Phase 3Updated Jun 10, 2026
Sponsor: AN2 Therapeutics, Inc
MAC Lung Disease · Treatment Refractory MAC Lung Disease
United States, Australia, Japan, South Korea
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCRecruiting
NCT05211895Phase 3Updated Jun 10, 2026
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer
United States, Belgium, Brazil, Canada, Chile +23 more
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated MothersCompleted
NCT06143046Phase 2Updated Jun 10, 2026
Sponsor: ModernaTX, Inc.
Respiratory Syncytial Virus
United States, Canada, Chile, Denmark, Japan +3 more
Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural MesotheliomaActive Not Recruiting
NCT06318286Phase 2Updated Jun 10, 2026
Sponsor: Hyogo Medical University
Malignant Pleural Mesothelioma
Japan
RegoNivo vs Standard of Care Chemotherapy in AGOCCompleted
NCT04879368Phase 3Updated Jun 10, 2026
Sponsor: Australasian Gastro-Intestinal Trials Group
Gastro-Oesophageal Cancer
United States, Australia, Austria, Germany, Italy +4 more
A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal DialysisRecruiting
NCT07548853Phase 3Updated Jun 10, 2026
Sponsor: Taisho Pharmaceutical Co., Ltd.
Hyperphosphatemia Patients on Peritoneal Dialysis
Japan
A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020)Completed
NCT05818137Phase 3Updated Jun 10, 2026
Sponsor: Merck Sharp & Dohme LLC
Pulmonary Arterial Hypertension
Japan
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)Recruiting
NCT06855771Phase 2Updated Jun 10, 2026
Sponsor: Bristol-Myers Squibb
Carcinoma, Non-Small-Cell Lung
United States, Australia, China, France, Germany +7 more
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsRecruiting
NCT07287995Phase 1, Phase 2Updated Jun 10, 2026
Sponsor: Astellas Pharma Global Development, Inc.
Locally Advanced or Metastatic Malignant Solid Tumors
United States, Japan
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With VitiligoActive Not Recruiting
NCT06118411Phase 3Updated Jun 9, 2026
Sponsor: AbbVie
Vitiligo
United States, Argentina, Belgium, Bulgaria, Canada +14 more
A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Healthy and Asthmatic ParticipantsCompleted
NCT06947408Phase 1Updated Jun 9, 2026
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Asthma
China
A Study of MT-2111 in Patients With Relapsed/Refractory DLBCLActive Not Recruiting
NCT05658562Phase 1, Phase 2Updated Jun 9, 2026
Sponsor: Tanabe Pharma Corporation
Diffuse Large B-Cell Lymphoma
Japan
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology ProductsActive Not Recruiting
NCT05476926N/AUpdated Jun 9, 2026
Sponsor: Hoffmann-La Roche
Neovascular Age-related Macular Degeneration · Diabetic Macular Edema · Retinal Vein Occlusion · Branch Retinal Vein Occlusion
United States, Argentina, Australia, Bulgaria, Canada +24 more
A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut SyndromeTerminated
NCT05163314Phase 3Updated Jun 9, 2026
Sponsor: Takeda
Dravet Syndrome (DS) · Lennox Gastaut Syndrome (LGS)
United States, Australia, Belgium, Brazil, Canada +15 more
Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABGRecruiting
NCT07192211Phase 2Updated Jun 9, 2026
Sponsor: Rohto Pharmaceutical Co., Ltd.
Ischemic Heart Disease
Japan
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to TreatmentActive Not Recruiting
NCT05455320Phase 3Updated Jun 9, 2026
Sponsor: Janssen Research & Development, LLC
Multiple Myeloma
United States, Belgium, Brazil, China, Czechia +13 more
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerRecruiting
NCT07005102Phase 2, Phase 3Updated Jun 8, 2026
Sponsor: AbbVie
Non-Squamous Non-Small Cell Lung Cancer
United States, Australia, Belgium, Canada, China +8 more
Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) InfectionTerminated
NCT06784973Phase 2Updated Jun 8, 2026
Sponsor: Gilead Sciences
RSV Infection
United States, Japan
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPActive Not Recruiting
NCT04971226Phase 3Updated Jun 8, 2026
Sponsor: Novartis Pharmaceuticals
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
United States, Australia, Austria, Belgium, Bulgaria +24 more
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Active Not Recruiting
NCT04720157Phase 3Updated Jun 8, 2026
Sponsor: Novartis Pharmaceuticals
Prostatic Neoplasms
United States, Austria, Belgium, Canada, China +14 more

Previous page Next page